US OptionsDetailed Quotes

NKTX240816C22500

Watchlist

0.23
0.000.00%

15min DelayClose Jul 22 16:00 ET

0.00High0.00Low

Nkarta Stock Discussion

Meltyy

May 16 01:19

🔔 RA Capital Q1 ‘24* Holdings Released... 🐳

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US)$
$Vaxcyte(PCVX.US)$
$Legend Biotech(LEGN.US)$
$Janux Therapeutics(JANX.US)$
$Aerovate(AVTE.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Evolent Health(EVH.US)$
$NewAmsterdam Pharma(NAMS.US)$
$RxSight(RXST.US)$
$TYRA BIOSCIENCES, INC.(TYRA.US)$
$Edgewise Therapeutics(EWTX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Biogen(BIIB.US)$
$PepGen(PEPG.US)$
...

Hashtags

Apr 2 11:14

$Nkarta(NKTX.US)$ jesus have some mercy

Trytosaveabit

Mar 25 05:35

$Nkarta(NKTX.US)$ Nkarta Prices Its Underwritten Offering Of 21M Shares At $10.00/Share And Pre-funded Warrants To Purchase 3M Shares At $9.9999/Warrant, With Gross Proceeds Of Approximately $240.1M

nekotaro

Mar 6 18:03

Lucky ~

I'll keep buying until the chart collapses! $Nkarta(NKTX.US)$

Share Your Profit/Loss

nekotaro

Mar 1 19:25

Late to buy but..

i have to grab it even at a high price to grow! $Nkarta(NKTX.US)$

Share Your Profit/Loss

Moomoo AI

Jan 21 06:32

The recent sale by Paul Hastings and the lack of insider buying over the last year could be a cause for concern. The relatively low insider ownership also raises caution. Therefore, the stock is not being rushed to buy.

Have Insiders Sold Nkarta Shares Recently?

The Evil Genius

Jan 8 09:46

Barely news but rocketed

$Nkarta(NKTX.US)$Nkarta Announces Updated Corporate Presentation To Reflect Business And Strategic Updates; Cash And Cash Equivalents $278.4M As Of Sept. 30, 2023

2F KILL CHEATERS

Dec 28, 2023 10:11

$Nkarta(NKTX.US)$ Meat Eaters be ready from tomorrow and...then we will have plenty of meat to đa on New Year 😋

TimeKeeper

Oct 18, 2023 10:18

$Nkarta(NKTX.US)$ LFG !

Moomoo AI

Oct 18, 2023 07:29

Despite Nkarta's solid cash runway, the increasing cash burn and its large size compared to the company's market capitalisation raise concerns over the potential risk. This could potentially lead to considerable share dilution if additional capital needs to be raised.

Will Nkarta (NASDAQ:NKTX) Spend Its Cash Wisely?

No comment yet